Obstacles impeding the development of nanocarriers for anticancer drugs

Nanomedicine (Lond). 2021 Jul;16(17):1447-1450. doi: 10.2217/nnm-2021-0101. Epub 2021 Jun 18.

Authors

Lingshan Liu¹, Hongjing Dou¹

Affiliation

¹ The State Key Laboratory of Metal Matrix Composites, School of Materials Science & Engineering, Shanghai Jiao Tong University, Shanghai 200240, PR China.

PMID: 34142559
DOI: 10.2217/nnm-2021-0101

No abstract available

Keywords: endocytosis; mononuclear phagocytic system; nanomedicine; protein corona; tumor penetration.

Publication types

Editorial
Research Support, Non-U.S. Gov't

MeSH terms

Antineoplastic Agents* / therapeutic use
Drug Carriers
Drug Delivery Systems
Nanomedicine
Nanoparticles*

Substances

Antineoplastic Agents
Drug Carriers